Comparing Outpatient and Inpatient Use of a Cervical Balloon for Starting Labor in Low-Risk Pregnancies.

NCT ID: NCT06983535

Last Updated: 2025-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

358 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-08-15

Study Completion Date

2024-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Why was this study done? About 20-30% of pregnancies involve labor being started artificially, known as induction. One way to do this is with a balloon catheter placed in the cervix, which helps prepare the body for labor. This mechanical method works just as well as using medication but may be safer for the baby, as it reduces the chances of the womb contracting too much (which can cause stress to the baby). Because it's safe and simple, this method could possibly be done at home instead of in the hospital.

What was the aim of the study? The researchers wanted to compare how safe and effective this balloon method is when used at home (outpatient) versus in the hospital (inpatient). They also wanted to know how satisfied women were with each approach.

How was the study done? The study took place at four hospitals in Belgium between 2017 and 2023. It included women with healthy low risk pregnancies who were scheduled for induction for non-urgent reasons, such as being past their due date, having a large baby, or by personal choice after 38 weeks of pregnancy.

The women were randomly placed into two groups:

Outpatient setting: going home after balloon placement.

Inpatient setting: staying in the hospital after balloon placement\<

The main thing researchers measured was whether the baby's heart rate pattern (checked by CTG monitoring) was abnormal after 12 hours. They also looked at how the baby was born (vaginal birth or C-section), how long labor took, whether additional medicine was needed, pain management, and how satisfied the mothers were with the process.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Design and Approval

This was a randomised controlled trial - a scientific study designed to compare two groups as fairly as possible. It took place in four hospitals in Belgium:

Ziekenhuis Oost-Limburg (ZOL), Genk

AZ Sint-Lucas, Brugge

Jessa Ziekenhuis, Hasselt

University Hospital Antwerp (UZA), Antwerp

The study ran from May 2017 to November 2023. It was carefully reviewed and approved by the Ethics Committee of ZOL Genk and the review boards of the other hospitals to make sure it followed strict ethical and safety standards.

Who Could Take Part?

Women were eligible to join the study if they:

Were over 18 years old

Were pregnant with just one baby

Had a baby in the head-down (cephalic) position

Had a Bishop Score of 6 or less (indicating the cervix wasn't ready for labor)

Needed their labor to be induced for low-risk reasons, such as:

Being past their due date (post-term)

Suspected large baby (macrosomia)

Personal request to induce labor after 38 weeks of pregnancy

Women were not allowed to join the study if they had any of the following:

Twins or more (multiple pregnancy)

Preterm premature rupture of membranes (water breaking too early)

A baby not growing well (fetal growth restriction)

A condition called placenta accreta spectrum (PAS)

A previous cesarean section

Baby not in head-down position

Gestational diabetes or high blood pressure during pregnancy

Lived more than 60 minutes away from the hospital

Any other health issues (maternal or fetal) or reason that made vaginal birth unsafe

How Were Women Assigned to Groups? Women were told about the study by their doctor in the days leading up to labor induction. On the day of induction, a hospital doctor checked if they met the criteria. If they did, the woman was asked to sign a consent form to take part in the study.

Once enrolled, each woman was randomly assigned to one of two groups:

Inpatient group - stayed in the hospital after balloon insertion

Outpatient group - went home after balloon insertion

The randomisation was done using a computer program, so neither the doctors nor patients could influence which group they were placed into. Because it was obvious who went home and who stayed, this study was not blinded.

The Induction Procedure All four hospitals had experience using mechanical methods to start labor. Before the study began, all staff received a brief training guide to ensure the procedure was done the same way in every hospital.

How the Balloon Was Inserted:

A double-balloon catheter (Cook balloon) was gently inserted into the cervix using a special tool under direct view with a vaginal speculum.

The lower balloon (inside the uterus) was first filled with 20 ml of saline.

The balloon was pulled back so that it rested properly in the cervix.

Then both balloons (one inside the uterus and one in the vagina) were gradually filled with saline up to 80 ml each.

The catheter was taped to the woman's thigh to keep it in place, but no tension or pulling was applied.

After insertion, each woman was monitored for 2 hours using CTG to check the baby's heart rate and any contractions.

If the CTG after balloon insertion was not normal (e.g., slow heartbeat, signs of stress), the woman stayed in the hospital, even if she was in the outpatient group.

Outpatient Group: Going Home If the CTG was normal, women in the outpatient group went home with the balloon still in place and were asked to return to the hospital 12 hours later, unless one of the following happened: their water broke (spontaneous rupture of membranes), they started having strong or painful contractions, the balloon came out or moved, they experienced non-tolerable pain or felt anxious, they simply didn't want to go home.

Before going home, every woman was given clear, written instructions about: when to come back early, what warning signs to look for, how to call the hospital, they also received a follow-up call from the doctor on duty 1-2 hours after leaving, to check how they were doing.

After 12 Hours: Balloon Removal and Next Steps. Twelve hours after the balloon was placed (or sooner, if needed), the balloon was removed. At that time the Bishop Score was checked again to see if the cervix had softened or opened. A new CTG was performed to make sure the baby was doing well.

What happened next depended on how the cervix looked: if the cervix was still not ready (Bishop Score ≤ 6):

→ Labor was continued using prostaglandins (a medication to soften the cervix)

If the cervix was ready (Bishop Score \> 6) and effaced (thinned out):

→ Labor was started by breaking the water (amniotomy) and giving oxytocin to strengthen contractions

If the cervix was open but not thinned, doctors often chose oral or vaginal prostaglandins instead of breaking the water.

All clinical details were recorded by trained hospital staff.

Primary Outcome (Main Focus):

The baby's wellbeing as seen on the CTG (heart rate monitor) right after the balloon was inserted and again when it was removed (or sooner if problems occurred).

Secondary Outcomes (Other Important Measures):

1. Maternal Clinical Outcomes:

How the baby was delivered (normal, assisted with vacuum or forceps, cesarean)

Pain relief used (e.g., paracetamol, pethidine, epidural)

Use of labor medications like oxytocin
2. Process Outcomes:

How long the entire induction process took:

From hospital admission to discharge

From balloon placement to delivery

From balloon removal to delivery
3. Maternal Satisfaction:

Assessed using a detailed 16-question survey sent by email 1-2 days after delivery

Topics included overall experience, comfort, timing, and whether they'd choose the same method again
4. Maternal Health Concerns:

Possible complications like:

Uterine hyperstimulation (too many contractions)

Placental abruption (placenta detaching early)

Infections needing antibiotics

Doctors also recorded why some women needed C-sections or assisted births.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Induction of Labor

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Inpatient

Patient in this arm were randomized to stay in the hospital during cervical balloon ripening

Group Type ACTIVE_COMPARATOR

cervical balloon catheter

Intervention Type DEVICE

Patients will be randomized to inpatient or outpatient setting while having the cervical ripening balloon catheter

Outpatient

Patients in this arm were randomized to ambulant home setting during cervical ripening

Group Type ACTIVE_COMPARATOR

cervical balloon catheter

Intervention Type DEVICE

Patients will be randomized to inpatient or outpatient setting while having the cervical ripening balloon catheter

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cervical balloon catheter

Patients will be randomized to inpatient or outpatient setting while having the cervical ripening balloon catheter

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women \>18 years of age with singleton pregnancies, cephalic presentation and a unfavourable cervix requiring priming (Bishop Score ≤ 6) that needed an IOL for low risk indications: post-term, macrosomia, patient's preference (\> 38 0/7 weeks of gestational age).

Exclusion Criteria

* : multiple pregnancies, preterm premature rupture of membranes (pPROM), foetal growth restriction (FGR), placenta-accreta spectrum (PAS), previous C-Section(s), non-cephalic presentation, gestational diabetes, hypertensive disorders of pregnancy, living at \>60 minutes from the hospital, any other maternal or foetal morbidity, any other contraindication to vaginal birth.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AZ Sint-Lucas Brugge

OTHER

Sponsor Role collaborator

University Hospital, Antwerp

OTHER

Sponsor Role collaborator

Jessa Hospital

OTHER

Sponsor Role collaborator

Ziekenhuis Oost-Limburg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Zoe Pieters

Role: STUDY_CHAIR

Data Science Institute, Hasselt University, Diepenbeek, Belgium.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospitals Antwerp

Antwerp, Antwerp, Belgium

Site Status

Ziekenhuis Oost-Limburg

Genk, Limburg, Belgium

Site Status

Jessa Ziekenhuis

Hasselt, Limburg, Belgium

Site Status

AZ Sint Lucas

Bruges, West-Vlaanderen, Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

References

Explore related publications, articles, or registry entries linked to this study.

Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Medley N, Dias S, Jones LV, Caldwell DM. Methods to induce labour: a systematic review, network meta-analysis and cost-effectiveness analysis. BJOG. 2016 Aug;123(9):1462-70. doi: 10.1111/1471-0528.13981. Epub 2016 Mar 22.

Reference Type BACKGROUND
PMID: 27001034 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

https://www.europeristat.com/publications/european-perinatal-health-report-2015-2019/

European Perinatal Health Report: Core Indicators of the Health and Care of Pregnant Women and Babies in Europe from 2015 to 2019. Euro-Peristat

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GYN2016.01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.